Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
Plozalizumab (MLN1202) is a monoclonal antibody that binds to and inhibits human chemokine receptor 2 (CCR2), potentially resulting in decreased tumor cell migration and proliferation (PMID: 21247529).
|CAS Registry Number||1610761-46-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|MLN1202 + Nivolumab||MLN1202 Nivolumab||0||1|